Newborn Resuscitation
3
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Rhapsode Capable Platform Intervention Group
Research Leaders
8 sponsors active, led by Helse Stavanger HF
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Enhancing Pediatric Acute Care Through Adaptive E-Learning and In-Person Skills Practice in Tanzania
PEEP Resuscitation Trial
The NeoBeat Efficacy Study for Newborns
Research Network
Common Treatments
- Rhapsode Capable Platform Intervention Group1
- Neobeat With A Visible Display1
- Paperbased Isp Control Group1
- Upright Resuscitator1
- Upright Resuscitator With Peep1
Active Sponsors
- Helse Stavanger HF2
- Haydom Lutheran Hospital1
- National Institutes of Health (NIH)1
- Sykehuset Østfold1
- Laerdal Medical1
Top Investigators
Muhimibili National Hospital
Catholic University of Health and Allied Sciences
Stavanger University Hosptial
Stanford University
Related Conditions
- Severe Malaria1
- Inservice Training1
- Computerassisted Instruction1
- Heart Rate Monitoring1
- Severe Dehydration1